SIG
VRTX icon

Stonegate Investment Group’s Vertex Pharmaceuticals VRTX Stock Holding History

Stonegate Investment Group’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$769K Sell
1,963
-4,179
-68% -$1.75M 0.02% 207
2025
Q2 		$2.73M Sell
6,142
-214
-3% -$98.6K 0.07% 113
2025
Q1 		$3.08M Sell
6,356
-153
-2% -$71.3K 0.08% 93
2024
Q4 		$2.62M Buy
6,509
+41
+0.6% +$19K 0.07% 105
2024
Q3 		$3.01M Sell
6,468
-274
-4% -$132K 0.08% 96
2024
Q2 		$3.16M Buy
6,742
+3,598
+114% +$1.56M 0.09% 89
2024
Q1 		$1.31M Sell
3,144
-132
-4% -$55.8K 0.04% 142
2023
Q4 		$1.33M Sell
3,276
-154
-4% -$56.9K 0.04% 142
2023
Q3 		$1.19M Sell
3,430
-392
-10% -$137K 0.04% 142
2023
Q2 		$1.34M Sell
3,822
-3
-0.1% -$1.01K 0.05% 139
2023
Q1 		$1.21M Sell
3,825
-470
-11% -$141K 0.05% 144
2022
Q4 		$1.24M Sell
4,295
-44
-1% -$13.4K 0.05% 123
2022
Q3 		$1.26M Sell
4,339
-370
-8% -$106K 0.06% 124
2022
Q2 		$1.33M Sell
4,709
-494
-9% -$132K 0.06% 129
2022
Q1 		$1.36M Sell
5,203
-544
-9% -$129K 0.04% 116
2021
Q4 		$1.26M Buy
+5,747
New +$1.12M 0.05% 119

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Stonegate Investment Group's VRTX Position: Q3 2025 in Review

Stonegate Investment Group reduced its Vertex Pharmaceuticals (VRTX) stake by 68% in Q3 2025, selling an estimated $1.75M and leaving 1,963 shares worth $769K. The position accounts for 0.02% of the portfolio, ranked #207.

Stonegate Investment Group first reported a position in VRTX in Q4 2021 and has held it in 16 quarters since. The position peaked at $3.16M in Q2 2024. 1,519 funds tracked by Wall St. Rank hold VRTX as of Q3 2025.

  • Stonegate Investment Group held 1,963 shares of Vertex Pharmaceuticals worth $769K as of Q3 2025.
  • Stonegate Investment Group sold 4,179 Vertex Pharmaceuticals shares in Q3 2025, an estimated $1.75M.
  • Vertex Pharmaceuticals made up 0.02% of Stonegate Investment Group's portfolio in Q3 2025, its #207 holding.
  • Stonegate Investment Group first reported a position in Vertex Pharmaceuticals in Q4 2021 and has held it in 16 quarters since.
  • Stonegate Investment Group's Vertex Pharmaceuticals position peaked at $3.16M in Q2 2024.
  • 1,519 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2025.

Based on Stonegate Investment Group's 13F filing for Q3 2025, filed 3 Nov 2025.